Cytokinetics
CYTK
#2392
Rank
โ‚น754.21 B
Marketcap
โ‚น6,071
Share price
7.37%
Change (1 day)
67.31%
Change (1 year)

Revenue for Cytokinetics (CYTK)

Revenue in 2025 (TTM): โ‚น7.62 Billion

According to Cytokinetics 's latest financial reports the company's current revenue (TTM ) is โ‚น8.35 Billion. an increase over the revenue in the year 2024 that were of โ‚น1.58 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cytokinetics from 2003 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น7.90 B398.68%
2024 โ‚น1.58 B152.82%
2023 โ‚น0.62 B-91.99%
2022 โ‚น7.82 B49.32%
2021 โ‚น5.24 B28.39%
2020 โ‚น4.08 B113.1%
2019 โ‚น1.91 B-13.01%
2018 โ‚น2.20 B158.05%
2017 โ‚น0.85 B-88.2%
2016 โ‚น7.23 B279.68%
2015 โ‚น1.90 B-35.98%
2014 โ‚น2.97 B57.12%
2013 โ‚น1.89 B357.49%
2012 โ‚น0.41 B95.59%
2011 โ‚น0.21 B83.31%
2010 โ‚น0.11 B-96.95%
2009 โ‚น3.78 B533.76%
2008 โ‚น0.59 B11.67%
2007 โ‚น0.53 B286%
2006 โ‚น0.13 B-65.47%
2005 โ‚น0.40 B-31.11%
2004 โ‚น0.58 B20.73%
2003 โ‚น0.48 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚น3.487 T 41,644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
โ‚น51.81 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น25.44 B 204.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚น10.97 B 31.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚น121.86 B 1,358.60%๐Ÿ‡บ๐Ÿ‡ธ USA